Mon, July 12, 2021
Sat, July 10, 2021
Fri, July 9, 2021
Thu, July 8, 2021
Wed, July 7, 2021
Tue, July 6, 2021
Mon, July 5, 2021
Fri, July 2, 2021
Thu, July 1, 2021
Wed, June 30, 2021
Tue, June 29, 2021
Mon, June 28, 2021
Fri, June 25, 2021
Thu, June 24, 2021
Wed, June 23, 2021

Amit Hazan Downgraded (BVS) to Hold and Decreased Target to $19 on, Jul 1st, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-19-on-jul-1st-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Amit Hazan of Goldman Sachs, Downgraded "Bioventus Inc." (BVS) to Hold and Decreased Target from $20 to $19 on, Jul 1st, 2021.

Amit has made no other calls on BVS in the last 4 months.



There are 3 other peers that have a rating on BVS. Out of the 3 peers that are also analyzing BVS, 0 agree with Amit's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Amit


  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $19 on, Monday, April 19th, 2021
  • Kyle Rose of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $23 on, Monday, March 8th, 2021
  • Robbie Marcus of "JP Morgan" Initiated at Buy and Held Target at $17 on, Monday, March 8th, 2021

Publication Contributing Sources